press releases

  • Glooko to Present Patient Outcomes Showing Impact of Remote Patient Monitoring and Coaching on Glycemic Control in Type 2 Diabetes

    June 25, 2021

    A study of the use of remote patient monitoring (RPM) with diabetes patients demonstrated improved and sustained glycemic control at 3-, 6- and 12-month intervals among people with type 2 diabetes (PWT2D). Participants remotely shared their glucose data with care teams and received remote-based coaching interventions. The data will be presented during a poster session beginning today at the 81st Scientific Sessions (virtual) of the American Diabetes Association and are sponsored by Glooko, Inc.

  • Glooko Announces Digital Health Collaboration with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets

    May 6, 2021

    Glooko Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions, today announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions.

  • Glooko Raises $30 Million Financing Round

    March 16, 2021

    Glooko Inc., a leading provider of remote patient monitoring and chronic care management solutions including diabetes and obesity has raised a $30 million Series D round of funding.

  • Glooko Announces New Medical Education Programme In Collaboration with the Diabetes Technology Network (DTN) / Association of British Clinical Diabetologists (ABCD)

    October 28, 2020

    Glooko AB (“Glooko” or “The Company”) today announced, in partnership with the Diabetes Technology Network (DTN)/ Association of British Clinical Diabetologists (ABCD), a new online medical education programme for clinicians who treat people with diabetes in the UK.

  • Glooko announces the addition of Tracy Bahl and Mike Doherty as Independent Members of the Board

    August 12, 2020

    As Glooko continues its journey to transform digital health by connecting people with diabetes and their health care professionals, enabling telehealth, clinical research, and improved collaboration, today they announced the addition of Tracy Bahl and Mike Doherty as independent members of the Board of Directors to provide guidance and support to the continued growth of the business.

  • Glooko provides Free Remote Care solution and collaborates with Sanofi to share with medical clinics and people with diabetes

    July 9, 2020

    Together, with Sanofi’s nearly 100-year heritage in diabetes and Glooko’s leadership in remotely connecting people living with diabetes and health care professionals, the companies will collaborate to provide people with diabetes with a digital health solution* to help manage their disease under the virtual guidance of their care teams.

  • Glooko Names Kyle Brown as Chief Technology Officer

    April 9, 2020

    As part of its continued focus on delivering data enabled solutions to improve the lives of people with diabetes, Glooko, the leader in diabetes digital health, data management solutions and remote monitoring solutions, today announced the appointment of Kyle Brown as Chief Technology Officer.

  • Glooko Enables Remote Patient Care at No Charge to Medical Clinics and People with Diabetes to Minimize Risk During Pandemic

    March 19, 2020

    Throughout this challenging time of the COVID-19 pandemic, Glooko, a leading diabetes software company that enables people with diabetes and clinicians to manage care in real-time, is committed to helping ensure the health and well-being of people with diabetes, their caregivers, and their healthcare professionals.

  • Glooko Names Zach Henderson as Chief Commercial Officer and Komathi Stem as Chief Operating Officer

    February 13, 2020

    As part of its continued global expansion, Glooko, the leader in diabetes digital health and data management solutions, today announced the appointment of Zach Henderson as Chief Commercial Officer and Komathi Stem as Chief Operating Officer.

  • Glooko Earns Privacy Shield Certification for Policies to Safeguard Diabetes Patient Data

    December 11, 2019

    Glooko®, the global leader in diabetes data management, today announced it has received Privacy Shield certification from the U.S. Department of Commerce. This official recognition verifies the company has taken specific steps to ensure the protection of consumers’ personal data when transferring it from Europe to the U.S.

  • Glooko Receives ISO 13485 Certification

    December 10, 2019

    Glooko®, the global leader in diabetes data management, announced today that its Mountain View, California and Gothenburg, Sweden sites have received joint ISO 13485:2016 certification from accredited certification body Intertek Testing Services NA Ltd.

  • Glooko’s diasend Diabetes Data Platform to Unveil Greater Connectivity and System Enhancements at EASD Meeting in Barcelona

    September 17, 2019

    Glooko®, the leader in diabetes data management solutions, continues to strengthen its global position with the introduction of several new features and expanded connectivity capabilities for the diasend® by Glooko system at this week’s 55th annual meeting of the European Association for the Study of Diabetes (EASD).

  • Glooko Appoints Stephen Lien as New Chief Financial Officer

    July 16, 2019

    Glooko®, the global leader in diabetes data management solutions, today announced the appointment of Stephen Lien as Chief Financial Officer. Lien comes to Glooko with relevant and extensive experience serving in senior leadership roles in finance and operations across a range of related industries.

  • Companion Medical and Glooko Announce Partnership Agreement to Integrate Insulin Data for Multiple Daily Injections

    June 5, 2019

    Companion Medical, a leader in the development of advanced insulin delivery technology to improve diabetes care, and Glooko, a leader in diabetes data visualization and management, have announced an integrated data partnership agreement that will enable insulin data from users of the InPen™ Smart Insulin Injection Pen to be integrated into the Glooko® Enterprise diabetes data management system and Glooko® Mobile App. This integration, through Apple Health, will allow users to automatically integrate their insulin data with the Glooko diabetes data management system for clinical evaluation by their healthcare professionals.

  • Glooko Names Dr. Mark Clements as New Chief Medical Officer

    May 21, 2019

    ​Glooko, the leader in diabetes data management solutions, today announced the appointment of Mark Clements, MD, PhD, CPI, FAAP, as Chief Medical Officer. Dr. Clements joins the senior management team of Glooko having served on its medical advisory board since it was formed in 2015 to provide expertise to the organization in the areas of clinical studies and diabetes analytics.

  • Glooko Mobile App Now Free For All People with Diabetes!

    March 5, 2019

    Glooko, the leader in diabetes data management, announced today its mobile app (available for Android and iOS) is now free* for any person with diabetes.

  • Glooko announces on-the-go insulin pen data uploads via diasend®, increased CGM compatibility – and the all-new Annual Diabetes Report

    February 19, 2019

    Glooko, the leader in diabetes data management, is gearing up for the ATTD trade show (Advanced Technologies & Treatment for Diabetes) with several exciting announcements: the launch of Novo Nordisk connected insulin pens on the diasend® platform, compatibility with the Dexcom G6 continuous glucose monitor – and the release of its Annual Diabetes Report, which will be presented to the audience in Berlin later this week.

  • New customers and partnerships contribute to Glooko’s 2018 success and set stage for accelerated growth

    January 24, 2019

    Glooko, the leader in diabetes data management, had a successful 2018 fueled by strong growth in health system customers, international expansion, and new partnerships. The recent success creates a strong foundation for continued momentum in 2019.

  • Novo Nordisk plans first global launch of connected insulin pens and announces key digital health partnerships

    October 1, 2018

    Novo Nordisk today announced plans to make the durable, connected insulin pens NovoPen® 6 and NovoPen Echo® Plus commercially available across key markets commencing in early 2019. In parallel, to support the future integration of its connected pens with broader digital health solutions, Novo Nordisk has signed new partnership agreements with leading diabetes technology companies that share Novo Nordisk’s vision to improve the lives of people with diabetes: Dexcom, Glooko and Roche.

  • Insulet Extends Partnership with Glooko in Europe to Optimise Diabetes Data Management

    July 12, 2018

    Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that it has partnered with Glooko®, Inc. to connect Insulet’s Omnipod System user data with Glooko+diasend®, the most comprehensive diabetes data management system available, across Europe.

  • Glooko Releases New Version of Mobile App, Presents Usability Outcomes from Mobile Insulin Dosing System (MIDS) Study

    June 22, 2018

    Glooko, the leader in diabetes data management, today announced participation in the 78th Annual American Diabetes Association (ADA) meeting taking place this weekend in Orlando, Fla.

  • DreaMed Diabetes Granted FDA Authorization to Market Advisor Pro, Offering Personalized Optimization of Insulin Pump Therapy

    June 18, 2018

    DreaMed Diabetes, developer of personalized diabetes management solutions, announced today that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software.

  • Glooko Introduces New Web Analytics Platform That Includes the Most Powerful Capabilities from Diasend

    June 11, 2018

    Glooko, the leader in diabetes data management, today announced the delivery of a new version of the Glooko Web Application (Population Tracker) that includes streamlined navigation and a large array of diabetes analytics, charts and graphs.

  • Senseonics & Glooko Announce Partnership on Integrated Diabetes Management

    June 10, 2018

    (NYSE-American: SENS), a medical technology company focused on the development and commercialization of transformative glucose monitoring products, today announced a partnership with Glooko, Inc, the leading diabetes data management company.

  • Glooko Study Highlights Insights Into How Diabetes Healthcare Professionals Use Continuous Glucose Monitoring (CGM) Data

    May 15, 2018

    Glooko, the leader in diabetes data management, today announced the results of its recent study which  examined diabetes healthcare professionals’ use of CGM data. The study asked 38 diabetes healthcare professionals (29 endocrinologists; nine diabetes educators) to assess CGM data from 10 people with type 1 diabetes within the Glooko platform.

  • Valeritas Teams with Glooko as its Preferred Data Management Partner for V-Go® SIM™

    April 20, 2018

    (NASDAQ: VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it has entered into an agreement with Glooko, a leader in diabetes data management.

  • Healthcare Technology Veteran, Russ Johannesson joins Glooko as CEO

    April 10, 2018

    Glooko, the leader in diabetes data management, today announced the appointment of Russ Johannesson as its new CEO. Outgoing CEO, Rick Altinger, will remain with Glooko as the Executive Vice President of Corporate Development.

  • Glooko Improves Medical Group Patient Outcomes with Remote Diabetes Care Program

    March 14, 2018

    Glooko, the leader in diabetes data management, today announced the results of its pilot program with Sharp Rees-Stealy Medical Group that aimed to optimize data-driven decisions for type 2 diabetes patients with high A1c levels. The six-month program revealed strong improvements in average blood glucose levels, patient adherence and engagement.

  • FDA Clears Glooko’s Long-Acting Insulin Titration System

    February 14, 2018

    Glooko, the leader in diabetes data management, today announced its Mobile Insulin Dosing System (MIDS) has been cleared by the Food and Drug Administration for the titration of long-acting insulin for people with type 2 diabetes. Glooko’s MIDS is the first insulin titration application accessible through a unified diabetes management platform, which provides a complete program for diabetes management.

  • Annual Glooko Study Identifies Global Diabetes Insights

    February 5, 2018

    Glooko, the leader in diabetes data management, today released its annual, comprehensive diabetes report based on analysis of over 8.5 billion de-identified data points. The report observes trends based on information collected from more than 1.5 million people with diabetes (PWDs) globally and includes by-country views of glycemic trends, occurrences of hyperglycemia and hypoglycemia, and insulin usage.

  • Strong Growth in 2017 Among Health Systems and Payers Propels Glooko into 2018

    January 24, 2018

    Glooko, the leader in diabetes data management, today announced that recent growth in its Health System and Payer customer base is driving strong momentum for 2018 and beyond.

  • Feasibility Study Shows Glooko’s Mobile Health App Improves Glycemic Control in People with Type 2 Diabetes

    October 30, 2017

    Glooko, the leader in diabetes data management, announced the results of a feasibility study that examined the impact of Glooko’s product, the Mobile Insulin Dosing System (MIDS) on glycemic control of people with type 2 diabetes on long acting insulin. MIDS is currently available for investigational use only.

  • Novo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management

    July 12, 2017

    Novo Nordisk and Glooko have announced that the new Cornerstones4Care Powered by Glooko app (C4C app) is now available to help people more effectively manage their diabetes. The C4C mobile app marries Novo Nordisk’s extensive knowledge of diabetes and personalized patient support with Glooko’s digital platform and data analytics expertise. This is the first jointly developed product from the two companies since announcing their collaboration in January 2017.

  • Diabetes Data Platform Leader Glooko Raises $35 Million in Series C

    June 27, 2017

    Glooko, the leader in diabetes data management, today announced $35 million in new funding to accelerate growth, expand international presence, and deepen expertise in data analytics. This round was led by Georgian Partners, a Toronto-based investor focused on applied analytics and machine learning.

  • Retrospective Studies Show that Glooko’s Mobile Health App Helps to Improve Outcomes for People with Diabetes

    June 9, 2017

    Glooko, the leader in diabetes data management today announced the results of two retrospective studies that examine the clinical impact of use of its diabetes management mobile application. The studies found that using the Glooko mobile app was associated with a drop in average blood glucose, estimated A1C (eA1C) and hyperglycemia rates in people with diabetes.

  • Glooko and Dexcom Expand Relationship with Global Cloud Sharing Data Agreement

    May 31, 2017

    Glooko, the leader in diabetes data management, today announced an expanded agreement with Dexcom, the leader in Continuous Glucose Monitoring (CGM) for people with diabetes.

  • Fit4D and Glooko Join Forces To Provide End-to-End Solution for Diabetes Management

    April 27, 2017

    Fit4D, a diabetes patient engagement solution, announced a partnership today with Glooko, a global diabetes data management company, to deliver highly personalized, data-driven coaching and a mobile health solution to patients and care providers.

  • INDUSTRY LEADERS ASCENSIA DIABETES CARE AND GLOOKO ANNOUNCE DIABETES TECHNOLOGY PARTNERSHIP TO DELIVER INTEGRATED DIABETES DATA SOLUTIONS

    January 31, 2017

    Ascensia Diabetes Care and Glooko, Inc today announced a global technology partnership designed to bring together their state-of-the-art diabetes management solutions, and improve diabetes data management and analytics. This collaboration includes integration of Glooko’s Diabetes Data Management Platform and Ascensia’s CONTOUR®NEXT ONE and CONTOUR®PLUS ONE blood glucose monitoring systems.

  • Novo Nordisk and Glooko partner to develop digital health solutions for people with diabetes

    January 9, 2017

    Novo Nordisk and Glooko today announced that the two companies will work together to deliver jointly-developed and branded digital health solutions for people with diabetes. The non-exclusive collaboration will combine Novo Nordisk’s deep knowledge of diabetes with Glooko’s digital platform and data analytics expertise.

  • The Combined Glooko and Diasend Release Their 2016 Diabetes Data Annual Report

    November 14, 2016

    Glooko, the leader in diabetesremote patient monitoring, today released its annual, comprehensive diabetes data report based on over 4.3 billion deidentified diabetes data points. The data in the report includes insights derived from the combined datasets of Glooko, Inc. and Diasend.

  • Atrius Health, a Pioneer Accountable Care Organization in Boston, Discusses How They Use Glooko to Remotely Monitor People with Diabetes

    October 21, 2016

    Atrius Health has always been an innovator when it comes to providing services to their patients.

  • Glooko and Diasend Merge to Deliver the World’s Premier Diabetes Management Platform

    September 13, 2016

    For people either living with or caring for people with diabetes, Glooko and Diasend are well-known for making diabetes management easier by offering best-in-class diabetes management and analytics platforms that facilitate data driven care for patients and clinicians.

  • AMC Health and Glooko Partner to Deliver Diabetes Population Management Services and Improve Diabetes Outcomes

    July 7, 2016

    AMC Health, the leading provider of proven remote patient monitoring and engagement solutions that are exclusively endorsed by the American Hospital Association, and Glooko Inc., the leading population health platform for diabetes management, today announced a partnership to help clinicians and patients improve diabetes outcomes at lower costs.

  • Glooko Announces Compatibility With Medtronic MiniMed Insulin Pumps and Sensors at the 2016 American Diabetes Association Conference

    June 10, 2016

    Glooko Inc., the leading unified platform for diabetes management, today announced compatibility with Medtronic MiniMed ® insulin pumps and sensors.

  • Glooko announces new ‘Glooko Advise’ decision support product line at the 2016 American Diabetes Association Conference

    June 9, 2016

    Glooko Inc., the leading unified platform for diabetes management, today announced its new ‘Glooko Advise’ product line, including ‘Glooko Personal Advisor’ and ‘Glooko Clinical Advisor,’ which enables both people with diabetes (PWDs) and clinicians with practical diabetes decision support.

  • Glooko and DreaMed Diabetes Partner to Deliver Unprecedented Type 1 Diabetes Decision Support

    February 3, 2016

    Glooko, Inc., provider of the leading unified platform for diabetes management, and DreaMed Diabetes, developer of innovative and patient-centric decision support technologies for insulin-dependent people with diabetes (PWDs), today announced a partnership to commercialize DreaMed’s Advisor algorithm using the Glooko platform. The partners will demonstrate the integrated solution at the Advanced Technologies & Treatments for Diabetes (ATTD) conference, from 3 – 6 February 2016 in Milan, Italy.

  • Pilot shows smartphone app and population management-­facilitated Type-­2 diabetes management can significantly improve blood glucose control

    October 29, 2015

    Glooko, the leading unified platform for diabetes management, today  announced that Glooko was featured in a poster presentation on the effectiveness of Glooko-enabled Type 2 diabetes management resulting from a pilot conducted at the Diabetes & Glandular Disease (DGD) Clinic.

  • Glooko Announces Integration with the Roche Accu-Chek® Aviva Connect Blood Glucose Meters

    September 24, 2015

    Glooko Inc., the leading unified platform for diabetes management, today announced general availability of its integration with Roche ’s Accu-Chek Aviva Connect blood glucose meters to send blood glucose (BG) results automatically to the Glooko platform. Through wireless Bluetooth Smart technology built into these Accu-Chek Aviva Connect meters, the release enables near real-time syncing of blood glucose data to the Glooko platform without the need to connect cables.

  • Glooko launches ‘Glooko Office Kiosk’ Package Offering for In-Clinic Diabetes Care

    September 1, 2015

    Glooko Inc., today announced the official launch of its “Glooko Office Kiosk” package, which for the first time enables diabetes data from popular blood glucose meters, insulin pumps, and continuous glucose monitors (CGMs) to be synced to an Android tablet and visualized in aggregate on Glooko’s mobile, cloud-based diabetes management platform.

  • Diabetes Thought Leaders Join the Glooko Medical Advisory Board

    July 9, 2015

    Glooko Inc​., the leading unified platform for diabetes management, today announced the formation of its first Medical Advisory Board who will provide Glooko with clinical expertise in the area of diabetes analytics and clinical studies.

  • Medtronic expands access to diabetes device data through agreement with Glooko

    June 5, 2015

    Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced an agreement with Glooko, the trusted leader in diabetes data unification and analytics, to improve access to meaningful diabetes health data in a safe and secure way.

  • Glooko to Highlight Integration of Insulin Pump and Continuous Glucose Monitor (CGM) Data into Its Diabetes Management Platform at ADA 2015 Conference

    June 3, 2015

    Glooko Inc. today announced it will demonstrate its integration with Insulin Pumps and Continuous Glucose Monitors (CGMs) at the American Diabetes Association’s 75 th Scientific Sessions , adding to the diabetes population management platform’s existing support for 30+ blood glucose meters, popular activity trackers, and biometric monitors for blood pressure and weight .

  • Glooko partners with Dexcom® and Insulet® to add leading insulin pump and CGM devices to its platform

    June 3, 2015

    Glooko Inc. today announced partnerships with Dexcom, Inc., developer and marketer of a continuous glucose monitoring (CGM) system, and with Insulet Corporation, the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System.

  • Glooko Appoints Serdar Akin as Vice President of Product Development and Michelle de Haaff as Vice President of Marketing and Customer Success

    April 23, 2015

    Glooko Inc., the leading unified platform for diabetes management, today announced the addition of two new executives to its management team.

  • Glooko, the Leading Remote Patient Monitoring Platform for Diabetes, Raises $16.5 Million in Series B Funding From Canaan Partners, Medtronic, Social + Capital and Samsung Glooko

    March 17, 2015

    Glooko Inc. today announced that it has raised $16.5 Million in Series B financing. The funds will be used to expand the company’s FDA-cleared, HIPAA-compliant platform to include device data from insulin pumps, continuous glucose monitoring systems and integration of personalized predictive algorithms.

  • Glooko Announces Integration of Wearable Activity & Biometric Monitors into Diabetes Management Platform

    November 12, 2014
  • Glooko Launches ‘MeterSync Blue’ to Bluetooth-Enable Tens of Millions of Blood Glucose Meters Worldwide

    October 2, 2014

    Glooko Inc., announced today the launch of Glooko MeterSync Blue, strengthening its position as the industry leader in delivering a mobile, software as a service (SaaS) diabetes remote monitoring and population management platform.

  • Joslin Institute of Technology Translation (JITT) and Glooko, Introduce Hypoglycemia Awareness Product Designed to Improve Hypoglycemia Self-Management for People with Diabetes

    June 11, 2014

    Joslin Institute for Technology Translation (JITT) at Joslin Diabetes Center, the world’s preeminent institution in diabetes research and clinical care, and Glooko Inc., a mobile, cloud based diabetes management system announced the release of their jointly developed Joslin HypoMap™ powered by Glooko™.

  • Joslin Diabetes Center Teams with Glooko on Next Generation Diabetes Management Solution

    January 21, 2014

    Joslin Diabetes Center, the world’s pre 7 eminent institution in diabetes research and clinical care, and Glooko Inc. have signed an agreement to jointly deploy an advanced diabetes management technology platform that will allow patients to share diabetes management data and in turn use that data through decision 7 making algorithms for optimal and predictive diabetes care. Glooko and Joslin will jointly provide a diabetes management solution globally to health systems , governments and payer groups aiming to improve health outcomes and lower costs.

  • Glooko Raises $7 Million to Enhance Diabetes Management System

    January 8, 2014

    Glooko Inc., makers of a FDA-cleared mobile diabetes management system , announced today it has raised $7 million in a Series A-1 round from several new investors including Samsung Venture Investment Company (SVIC ) and Lifeforce Ventures as well as existing investors including The Social + Capital Partnership , Sundeep Madra and Yogen Dalal. Using this investment, Glooko will focus on enabling predictive diabetes care by delivering patient data and decision-making algorithms to health providers and payer groups.

  • Glooko Launches Diabetes Management System for Android

    October 29, 2013

    Glooko, Inc., makers of an innovative mobile solution for diabetes management, today announced it has launched an Android – compatible version of its next generation Glooko Diabetes Management System .

  • Glooko Receives FDA 510(k) Clearance for new Diabetes Management System, Hires Diabetes Industry Executives Holly McGarraugh as VP of Business Development and Rita Sharma as VP of Marketing

    May 2, 2013

    Glooko, Inc., makers of an innovative mobile solution for diabetes management , has received FDA 510(k) clearance for its next-gen Glooko System including its Glooko iPhone application, MeterSync Cable and web dashboards for both patients and healthcare providers . In addition, the company has announced the hiring of Holly D. McGarraugh as Vice President of Business Development and Rita Sharma as Vice President of Marketing .

  • Glooko Hires Former Intuit Health Executive Rick Altinger as CEO and Epocrates Executive Dean Lucas as VP of Product Development, Receives FDA 510(k) Clearance

    January 17, 2013

    Glooko, Inc., makers of an innovative mobile logbook solution for people with diabetes, today announces the hiring of Rick Altinger as CEO and Dean Lucas as vice president of product development.

  • Backed by Former Facebook VP Chamath Palihapitiya, Glooko Steps Up Presence in Canada

    October 8, 2012

    Glooko, Inc., makers of an innovative mobile logbook solution for people with diabetes , today formally introduces its Glooko ™ Logbook app and Glooko MeterSync Cable for iOS devices in Canada.

  • Glooko Launches Version 1.5 of its Blood Sugar Logbook App

    September 28, 2012

    Glooko, Inc. , makers of an innovative mobile solution for people to log blood sugar readings, today announces Glooko ™ Logbook 1.5 for iOS devices , with new support for six additional popular blood glucose meters.

  • Glooko Officially Launches in EU

    June 27, 2012

    Glooko, Inc ., makers of an innovative mobile logbook solution for people with diabetes , today officially launches its Glooko™ Logbook Charts in the European Union and Glooko Logbook History Report in the US, Canada and European Union.

  • Glooko Launches the Glooko IR Adapter for ACCU-CHEK

    May 30, 2012

    Glooko, Inc., makers of an innovative diabetes logbook solution, and Roche Diabetes Care, makers of ACCU-CHEK blood glucose monitoring systems, insulin pumps and information management solutions, today announced their co-promotion of the Glooko Logbook solution in the U.S .

  • The Social+Capital Partnership Invests in Mobile Diabetes Company Glooko

    January 30, 2012

    Glooko, provider of a unique hardware device and app solution for people with diabetes, today announced a $3.5 Series A financing round, led by The Social+Capital Partnership, with participation from existing investors.